Navigation Links
SeprOx Receives Texas Emerging Technology Fund Award
Date:6/11/2009

THE WOODLANDS, Texas, June 11 /PRNewswire/ -- SeprOx Corporation received a pre-seed commercialization award from the Texas Emerging Technology Fund (ETF) presented by Governor Rick Perry at Texas Technology Leadership Day held this past Friday at the Houston Technology Center. SeprOx will receive an initial investment of $250,000 and is eligible to receive up to $1 million in total funding.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090611/DA30680LOGO)

"Too often, great ideas are shelved with no clear path to the marketplace when grants run out or new projects are started, when they could improve people's lives. The Emerging Technology Fund is our solution to that problem," Gov. Perry said. "The ETF is super-charging the research environment in our state, harnessing our people's amazing ideas, and encouraging even greater efforts to inquire, innovate and invest."

Established by Gov. Perry and the Texas Legislature in 2005, the ETF is bringing the best scientists and researchers to Texas, attracting high-paying jobs, and helping start-up companies get off the ground faster. The ETF program has been renewed to fund awards through August 2011.

"In spite of these uncertain economic times, it is exciting to see more companies from the Houston region commercializing breakthrough technology, solving real human problems, creating good jobs and building the region's and the state's reputation as a 21st century technology hub," said Walter Ulrich, president and CEO, Houston Technology Center.

"We are extremely appreciative of this vote of confidence by the Governor and the State of Texas and look forward to commercializing a product that will have a positive impact on the health and well-being of the people of Texas," commented Dr. Robert Schucker, CEO of SeprOx.

About SeprOx Corporation

SeprOx Corporation, located in The Woodlands, TX, was established in 2008 as a wholly owned subsidiary of Trans Ionics Corporation (TIC) to scale up and commercialize groundbreaking technology capable of separating virtually pure oxygen from air using a proprietary membrane material under exclusive license from the Texas Center for Superconductivity's Energy Materials Program at the University of Houston. Applications of the technology range from small medical oxygen generators to large industrial oxygen systems for clean coal combustion and gasification. The Company expects to complete fabrication of a working prototype of its five liter per minute portable medical oxygen generator for patients that have chronic obstructive pulmonary disease within twelve months. For more information, visit www.seprox.com.

About Houston Technology Center

Houston Technology Center (HTC), a business accelerator and the largest technology business incubator in Texas, accelerates the commercialization of emerging technology companies in the Greater Houston area. A 501(C)(3)non-profit organization, HTC assists Houston-based entrepreneurs within several key sectors: Energy, Information Technology, Life Sciences, Nanotechnology and NASA/Aerospace technologies, by providing in-depth business guidance, access to capital and service providers, and entrepreneurial education. For more information, visit www.houstontech.org.


'/>"/>
SOURCE SeprOx Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SHPS Receives Re-Accreditation from URAC for Multiple Health Management Programs
2. Herley Receives a $1.2 Million Contract Award for Complex Integrated Microwave Assemblies for U.S. Electronic Attack Aircraft
3. Elder Care Expert Doctor Marion Receives Accolades from Lehman College, Mature Market Resource Center in Same Week
4. Medifocus, Inc. receives Authorization Approval from Health Canada to launch its pivotal Phase III clinical study of focused microwave heating for treatment of breast cancer in Canada
5. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
6. MedApps Receives FDA Clearance on a New Way to Bring Cost-Effective Remote Health Monitoring to More People
7. Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms
8. Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device
9. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
10. XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration
11. Cepheid Receives Health Canada License for Xpert(R) HemosIL(R) FII & FV Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... December 02, 2016 , ... Halfway through its partnership with First 5 ... services to more than 15,900 children 5 years old and younger and treatment services ... over a span of five years to Western University of Health Sciences, UCLA and ...
(Date:12/2/2016)... Calif. (PRWEB) , ... December 02, 2016 , ... On ... at the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who ... neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership within ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of travel therapy ... MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason ... extensive financial and operational leadership experience to Advanced Inc. He began his career in ...
(Date:12/2/2016)... ... 02, 2016 , ... The annual time frame to change Medicare health and ... ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current ... need to make changes during this period order for their new policy to go ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)...  Former Attorney General of Louisiana , ... the law firm of Kahn Swick & Foti, LLC ("KSF"), ... Inc. (NYSE: LCI ). On ... "U.S. Charges in Generic-Drug Probe to Be Filed by Year-End," ... begun about two years ago, now spans more than a ...
(Date:12/4/2016)... , Dec. 3, 2016 Sickle cell disease ... sickle-shaped red blood cells that get stuck in veins ... stroke, organ failure, and complications leading to death. Each ... with SCD, and most of them lack access to ... only established long-term therapy for SCD, a pill called ...
(Date:12/4/2016)... A highly innovative, personalized cell-based treatment for a high-risk form of the ... from Children,s Hospital of Philadelphia today reported new ... (ALL). The physician-scientists presented findings at the annual meeting of ... . Continue Reading ... ...
Breaking Medicine Technology: